Logo image of PHGE

BIOMX INC (PHGE) Stock Price, Quote, News and Overview

NYSEARCA:PHGE - NYSE Arca - US09090D3017 - Common Stock - Currency: USD

0.599  -0.03 (-4.97%)

After market: 0.599 0 (0%)

PHGE Quote, Performance and Key Statistics

BIOMX INC

NYSEARCA:PHGE (3/7/2025, 8:04:01 PM)

After market: 0.599 0 (0%)

0.599

-0.03 (-4.97%)

Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryBiotechnology
Statistics
52 Week High4.99
52 Week Low0.48
Market Cap14.97M
Shares25.00M
Float14.89M
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)04-01 2025-04-01/amc
IPO12-18 2018-12-18


PHGE short term performance overview.The bars show the price performance of PHGE in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -10 -20 -30 -40

PHGE long term performance overview.The bars show the price performance of PHGE in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of PHGE is 0.599 USD. In the past month the price decreased by -18.51%. In the past year, price decreased by -85.97%.

BIOMX INC / PHGE Daily stock chart

PHGE Competitors/Peers

The largest stocks on the US markets in the "Biotechnology" sub-industry
Full List
Symbol
Name
TA
FA
PE
Market Cap
ABBV ABBVIE INC 21.17 378.30B
AMGN AMGEN INC 16.39 174.51B
GILD GILEAD SCIENCES INC 25.47 146.22B
VRTX VERTEX PHARMACEUTICALS INC 1683.76 125.39B
REGN REGENERON PHARMACEUTICALS 15.5 77.34B
ARGX ARGENX SE - ADR 231.21 36.10B
ALNY ALNYLAM PHARMACEUTICALS INC N/A 31.66B
ONC BEIGENE LTD-ADR N/A 26.47B
BNTX BIONTECH SE-ADR N/A 26.08B
BIIB BIOGEN INC 9.13 22.01B
NTRA NATERA INC N/A 19.02B
GMAB GENMAB A/S -SP ADR 24.89 15.34B

About PHGE

Company Profile

PHGE logo image Biomx Inc is a US-based company operating in Biotechnology industry. The company is headquartered in Gaithersburg, Maryland and currently employs 58 full-time employees. The company went IPO on 2018-12-18. BiomX Inc., formerly Chardan Healthcare Acquisition Corp., is a microbiome company. The firm is focused on developing both natural and engineered phage therapies. The company develops therapies to target and destroy bacteria that affect the appearance of skin, as well as harmful bacteria in chronic diseases, such as inflammatory bowel disease (IBD), primary sclerosing cholangitis (PSC) and cancer. The firm discovers and validates bacterial targets and customizes phage compositions against the targets. Its pipeline includes BX001, BX002 and BX003. BX001 is a product candidate that improves the appearance of acne-prone skin. BX002 is a customized phage cocktail that eradicates bacterial targets associated with the onset of IBD. BX003 is a customized phage cocktail developed against specific strains of Klebsiella pneumoniae (Kp).

Company Info

BIOMX INC

708 Quince Orchard Rd, Suite 205

Gaithersburg MARYLAND 7414002 US

CEO: Jonathan Solomon

Employees: 65

Company Website: https://www.biomx.com/

Investor Relations: http://ir.biomx.com/

Phone: 18449720500

BIOMX INC / PHGE FAQ

What is the stock price of BIOMX INC today?

The current stock price of PHGE is 0.599 USD. The price decreased by -4.97% in the last trading session.


What is the ticker symbol for BIOMX INC stock?

The exchange symbol of BIOMX INC is PHGE and it is listed on the NYSE Arca exchange.


On which exchange is PHGE stock listed?

PHGE stock is listed on the NYSE Arca exchange.


What is the price forecast or stock price prediction for BIOMX INC stock?

8 analysts have analysed PHGE and the average price target is 7.14 USD. This implies a price increase of 1091.99% is expected in the next year compared to the current price of 0.599. Check the BIOMX INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is BIOMX INC worth?

BIOMX INC (PHGE) has a market capitalization of 14.97M USD. This makes PHGE a Nano Cap stock.


How many employees does BIOMX INC have?

BIOMX INC (PHGE) currently has 65 employees.


What are the support and resistance levels for BIOMX INC (PHGE) stock?

BIOMX INC (PHGE) has a resistance level at 0.85. Check the full technical report for a detailed analysis of PHGE support and resistance levels.


Should I buy BIOMX INC (PHGE) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does BIOMX INC (PHGE) stock pay dividends?

PHGE does not pay a dividend.


When does BIOMX INC (PHGE) report earnings?

BIOMX INC (PHGE) will report earnings on 2025-04-01, after the market close.


What is the Price/Earnings (PE) ratio of BIOMX INC (PHGE)?

BIOMX INC (PHGE) does not have a PE ratio as the earnings reported over the last twelve months were negative (-5.3).


What is the Short Interest ratio of BIOMX INC (PHGE) stock?

The outstanding short interest for BIOMX INC (PHGE) is 0.07% of its float. Check the ownership tab for more information on the PHGE short interest.


PHGE Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

PHGE Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to PHGE. The financial health of PHGE is average, but there are quite some concerns on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

PHGE Financial Highlights

Over the last trailing twelve months PHGE reported a non-GAAP Earnings per Share(EPS) of -5.3. The EPS increased by 43.62% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -14.51%
ROE -22.97%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%552.62%
Sales Q2Q%N/A
EPS 1Y (TTM)43.62%
Revenue 1Y (TTM)N/A

PHGE Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 83% to PHGE. The Buy consensus is the average rating of analysts ratings from 8 analysts.


Ownership
Inst Owners46.75%
Ins Owners0.62%
Short Float %0.07%
Short Ratio0.1
Analysts
Analysts82.5
Price Target7.14 (1091.99%)
EPS Next Y50.83%
Revenue Next YearN/A